GSK plc (GSK, GLAXF) — 13F holdings

GSK plc (GSK, GLAXF) reported 13 holdings worth $602M in its 13F filing for Q2 2026, filed August 13, 2026.

Largest positions

1. CRSP CRISPR Therapeutics AG — $176M (29.2%)
2. WVE WAVE LIFE SCIENCES LTD — $106M (17.6%)
3. VIR VIR BIOTECHNOLOGY INC — $87.1M (14.5%)
4. BNTX BIONTECH SE — $82.8M (13.7%)
5. IDYA IDEAYA BIOSCIENCES INC — $49.7M (8.3%)
6. CYTK CYTOKINETICS INC — $29.0M (4.8%)
7. LYEL LYELL IMMUNOPHARMA INC — $21.3M (3.5%)
8. SPRO SPERO THERAPEUTICS INC — $20.3M (3.4%)
9. NKTX NKARTA INC — $8.92M (1.5%)
10. FULC FULCRUM THERAPEUTICS INC — $6.54M (1.1%)